The DOI matches its Crossref record.
Effectiveness of Amitriptyline in the Prophylactic Management of Childhood Headaches
Open accessAbstract
Objective.—To study the effectiveness of a standardized dose of amitriptyline, 1 mg/kg, for childhood headaches. Background.—Amitriptyline has been shown to be effective for the prophylaxis of migraine in adults. Studies in children, however, have been quite limited. In adults, the suggested effective dose range is 10 to 150 mg. In children, a standardized dosage is often not used, resulting in a dosage range in clinical practice that often varies from a very low dose to a dose equivalent to that used in adults. Methods.—Children with more than three headaches per month were treated with amitriptyline, slowly increasing the dose to 1 mg/kg per day. The frequency, severity, and duration of their headaches were initially evaluated and subsequently measured at each follow‐up evaluation. Two hundred seventy‐nine children had headaches occurring frequently enough to indicate prophylactic treatment. Of these children, 192 (68.8%) were treated with amitriptyline. The average age at presentation was 12.0 (± 3.0) years. The ratio of boys to girls was 1:1.74. The average frequency of headaches was 17.1 (± 10.1) days per month. The average severity was 6.84 (± 1.67) on a 10‐point pain scale. The average duration was 11.5 (± 15.0) hours. The most frequent diagnoses using International Headache Society criteria were migraine (60.6%), migraine with aura (7.9%), and tension‐type headache (10.4%). Of these children, 146 have been seen for at least one follow‐up examination, occurring on average 67.3 (± 32.3) days after beginning prophylactic treatment. Results.—A total of 84.2% of the children reported an overall perception of being better, while 11.6% reported being the same. The frequency of headaches improved to 9.2 (± 10.0) days per month. The average severity was reduced to 5.1 (± 2.1), and the average duration was reduced to 6.3 (± 11.1) hours. If daily or continuous headaches were excluded, the improvements were more marked. Minimal side effects were reported from these children and their families. Long‐term evaluation (156 to 415 days) showed continued sustained improvement. Conclusions.—Amitriptyline is an effective prophylactic medication for children with frequent headaches. A standardized dosing regimen results in a significant number of children responding with minimal side effects. The children are able to tolerate this dosing scheme and demonstrate good adherence to a dosing schedule of once a day.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lewis, D., Ashwal, S., Hershey, A., Hirtz, D., Yonker, M., & Silberstein, S. (2004) · Neurology · doi:10.1212/01.wnl.0000147332.41993.90 · Cited by 440
Self-citationAnalgesics for the Treatment of Pain in Children
Berde, C. B., & Sethna, N. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012626 · Cited by 439
Quality of Life in Childhood Migraines: Clinical Impact and Comparison to Other Chronic Illnesses
Powers, S. W., Patton, S. R., Hommel, K. A., & Hershey, A. D. (2003) · Pediatrics · doi:10.1542/peds.112.1.e1 · Cited by 390
Self-citationDepression and functional disability in chronic pediatric pain
Kashikar-Zuck, S., Goldschneider, K. R., Powers, S. W., Vaught, M. H., & Hershey, A. D. (2001) · The Clinical Journal of Pain · doi:10.1097/00002508-200112000-00009 · Cited by 357
Self-citationPowers, S. W., Kashikar-Zuck, S. M., Allen, J. R., LeCates, S. L., Slater, S. K., Zafar, M., Kabbouche, M. A., O’Brien, H. L., Shenk, C. E., Rausch, J. R., et al. (2013) · JAMA · doi:10.1001/jama.2013.282533 · Cited by 287
Self-citation
Metadata
- Authors
- Hershey, A. D., Powers, S. W., Bentti, A., & DeGrauw, T. J.
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 40
- Issue
- 7
- Pages
- 539-549
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W2095863636
- Cited by
- 208
- References
- 0
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Amitriptyline in the Prophylactic Management of Childhood Headaches. https://app.cochat.ai/papers/10.1046/j.1526-4610.2000.00085.x
- The paper
- Hershey, A. D., Powers, S. W., Bentti, A., & DeGrauw, T. J. (2000). Effectiveness of Amitriptyline in the Prophylactic Management of Childhood Headaches. Headache: The Journal of Head and Face Pain. https://doi.org/10.1046/j.1526-4610.2000.00085.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.